drugset / Trial / NCT03200704
A Study Assessing the Safety and Effectiveness of IC2000 and SPY Fluorescence Imaging Systems (SPY-PHI) in the Visualization of Lymphatic Vessels and Identification of Lymph Nodes During Sentinel Lymph Node Biopsy in Subjects With Breast Cancer
NaSingle-groupOpen-labelTreatment
Summary
This is a prospective, open label, multicenter, non-inferiority within-patient study to determine the effectiveness of IC2000 (Indocyanine Green (ICG) for Injection) and the SPY Portable Handheld Imaging System (SPY-PHI) as an intraoperative fluorescence visualization tool, in the visual identification of lymphatic vessels and lymph nodes (LNs) during lymphatic mapping and sentinel lymph node biopsy (SLNB) procedures as confirmed by Technitium99m (Tc99m) and Gamma Probe.
Timeline
- Start
- 2019-01-04
- Primary completion
- 2020-08-27
- Completion
- 2020-09-28
Outcome
Met primary endpoint
registry analysis (non-inferiority test); IC2000/SPY-PHI; p <0.0001; Regression, Logistic NCT03200704 ↗
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | IC2000 | Diagnostic / imaging agent | 0.05 ml | Intravenous |
| Subject | IC2000 | Diagnostic / imaging agent | 2.5 mg/ml | Intravenous |
| Background | Tc-99m radioactive colloid | Diagnostic / imaging agent | — | — |